Compare Bumble Inc (BMBL) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bumble Inc vs Twist Bioscience Corp — how do they compare? Bumble Inc trades at $2.99 (market cap $382.16M), while Twist Bioscience Corp trades at $93.26 (market cap $5.77B). The key difference: Twist Bioscience Corp is far larger — about 15.1× Bumble Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Bumble Inc nearer its low. Which is the better fit depends on your goals.
| BMBL | TWST | |
|---|---|---|
Market Cap | $382.16M | $5.77B |
Sector | Technology | Health |
52-Week High | $8.57 | $102.88 |
52-Week Low | $2.70 | $24.16 |
Enterprise Value | $733.84M | $5.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BMBL trades at $3.11, up 2.64% over 24 hours, with a neutral technical signal and bearish moving averages. The company reported a Q1 2026 EPS beat but faces declining revenue and a net loss of -$693.14M for 2025. Recent news highlights a potential sale exploration and an AI-driven product overhaul to counter slowing growth and payer declines.
Outlook remains speculative with a consensus price target of $4.37, offering 40% upside, but risks include persistent losses, high debt, and intense competition. Execution of the strategic reset is critical for a turnaround, with cash flow improvements providing a slight cushion amid operational challenges.
TWST trades at $90.35, down 0.31% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels near key support at $89. Revenue growth remains strong, reaching $376.57M in 2025, though the company continues to report net losses. Recent news highlights AI-driven drug discovery collaborations and insider selling activity, while analyst consensus leans bullish with a $91.63 price target.
The stock offers growth exposure to synthetic biology and AI-enabled therapeutics, but carries significant risk due to persistent negative cash flow and profitability challenges. Investor sentiment is cautiously optimistic, balancing innovation potential against financial sustainability concerns in a competitive biotech landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bumble Inc
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
